These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 3602018)
1. Pharmacokinetics and effects of isoxicam on renal function in patients with renal insufficiency. Brooks PM; McCredie M; Prowse M; Podgorski M; Forrest M; Munro I; Boutagy J; Pei-Ling L Pharmatherapeutica; 1986; 4(10):665-72. PubMed ID: 3602018 [TBL] [Abstract][Full Text] [Related]
2. Piroxicam pharmacokinetics: recent clinical results relating kinetics and plasma levels to age, sex, and adverse effects. Hobbs DC Am J Med; 1986 Nov; 81(5B):22-8. PubMed ID: 3538867 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic disposition of isoxicam in hepatic cirrhosis. Esquivel M; Ogilvie RI; East DS; Shaw DH; Heathcote J Clin Invest Med; 1987 Sep; 10(5):363-7. PubMed ID: 3677504 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of piroxicam: new aspects. Fenner H Eur J Rheumatol Inflamm; 1987; 8(1):42-8. PubMed ID: 3622592 [TBL] [Abstract][Full Text] [Related]
5. Effect of impairment of renal function on the accumulation and disposition of isoxicam. Bury RW; Whitworth JA; Saines D; Kincaid-Smith P; Moulds RF Eur J Clin Pharmacol; 1985; 28(5):585-8. PubMed ID: 4043201 [TBL] [Abstract][Full Text] [Related]
6. [Antirheumatic treatment in old age and its effect on kidney function]. Jansen W Med Klin; 1981 Aug; 76(17):476-8. PubMed ID: 7278786 [TBL] [Abstract][Full Text] [Related]
7. Plasma and synovial fluid concentrations of piroxicam during prolonged treatment with piroxicam pivalic ester. Chérié Lignière G; Montagnani G; Alberici M; Acerbi D Arzneimittelforschung; 1987 May; 37(5):560-3. PubMed ID: 3619977 [TBL] [Abstract][Full Text] [Related]
8. Single and multiple oral dose pharmacokinetics of tenoxicam in the elderly. Bird HA; Francis RJ; Le Gallez P; Hill J; Dixon JS; Allen JG; Wright V Eur J Rheumatol Inflamm; 1985; 8(1):60-9. PubMed ID: 3879831 [TBL] [Abstract][Full Text] [Related]
9. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite. Kirch W; Köhler H; Berggren G; Braun W Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021 [TBL] [Abstract][Full Text] [Related]
10. A comparison of isoxicam pharmacokinetics in young and elderly subjects. George CF; Renwick AG; Darragh AS; Hosie J; Blake D; van Marle W; Frank GJ Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):129S-134S. PubMed ID: 3620272 [TBL] [Abstract][Full Text] [Related]
11. Compared effects of isoxicam and indomethacin on the urinary excretion of prostaglandins in degenerative articular diseases. Sassard J; Geoffroy J; Ferry N; Benzoni D; Mathieu M; Lejeune E; Llorca G Prostaglandins Leukot Essent Fatty Acids; 1989 Nov; 38(2):107-11. PubMed ID: 2616586 [TBL] [Abstract][Full Text] [Related]
14. [Stevens-Johnson syndrome caused by isoxicam]. Capizzi R; Cacciaguerra MG; Guerriero G; Tulli A G Ital Dermatol Venereol; 1986; 121(6):461-2. PubMed ID: 3557542 [No Abstract] [Full Text] [Related]
15. Single- and multiple-dose pharmacokinetics, kidney tolerability and plasma protein binding of tenoxicam in renally impaired patients and healthy volunteers. Nilsen OG; Aasarød K; Widerøe TE; Guentert TW Pharmacol Toxicol; 2001 Nov; 89(5):265-72. PubMed ID: 11881981 [TBL] [Abstract][Full Text] [Related]
16. Diuretic effect and pharmacokinetics of tizolemide in subjects with normal and decreased renal function. Beermann B; Odlind B; Wibell L Clin Nephrol; 1983 Mar; 19(3):124-31. PubMed ID: 6839561 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of etodolac in subjects with renal impairment. Brater DC Eur J Rheumatol Inflamm; 1990; 10(1):44-55. PubMed ID: 2146131 [TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of isoxicam in elderly patients with rheumatoid arthritis. Grace EM; Rosenfeld JM; Sweeney GD; Buchanan WW Curr Med Res Opin; 1987; 10(9):580-91. PubMed ID: 3436154 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the efficacy and tolerance of a new non-steroidal anti-inflammatory agent, isoxicam]. Marcolongo R; Giordano N; Fioravanti A; Frati E; Mariani AM; Casini A Clin Ter; 1984 Dec; 111(6):513-9. PubMed ID: 6525811 [No Abstract] [Full Text] [Related]